GERARD ACHILLES OBNIAL: Open Payments
NPI 1427692144 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 9 payments from 7 companies in 2025. Trend: 2023 $730 · 2024 $312 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 3 | $276 |
| Optinose US, Inc. | 1 | $128 |
| Lilly USA, LLC | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $120 |
| Ascensia Diabetes Care Us Inc. | 1 | $104 |
| Paratek Pharmaceuticals, Inc. | 1 | $52 |
| HARTMANN USA, INC. | 1 | $29 |
Products named: Rezzayo, Xhance, DAYBUE, NUZYRA, ZETUVIT PLUS 10X10 P10, Kimyrsa.
Industry payments across TX — which companies pay providers there.
